Nicoracetam is a nootropic drug from the racetam family.

Elanzepine is an antidepressant compund.

Broxitalamic acid is tribromobenzoic acid derivative used as x-ray contrast medium

Enfenamic acid (under brand name tromaril) is an anthranilic acid derivative with potent anti-inflammatory, anti-arthritic, analgesic and antipyretic actions. It has additional unique property of anti-platelet aggregation activity, without disturbing any other blood coagulation factors. It also differs from other non-steroidal anti-inflammatory agents like indomethacin, in producing diuresis and natriuresis. In the clinical study, tromaril showed itself as a strong and effective drug for use in various eye diseases.

Eniclobrate (Sgd 33374), a diphenylmethane derivative, is a lipid-lowering compound. In rodents, eniclobrate lower serum and liver cholesterol levels and reduced the percentage of esterified cholesterol present in the serum but raised liver triglyceride levels. In a clinical trial for the treatment of hyperlipidemia type IIa and type IIb eniclobrate effectively reduced LDL-cholesterol in type IIa, however, there was a remarkable increase in HDL-cholesterol in both types of hyperlipidemia.

Enilospirone (CERM-3726) is essentially a central stimulant. At low doses (100 mg) it may improve performance and at higher doses it may lead to disturbance of sleep continuity. These effects may not involve DA mechanisms, though changes such as those in REM sleep with chronic ingestion could involve the noradrenergic pathway. The property of the drug, even at low doses, to oppose the deterioration in performance associated with tests of prolonged duration is likely to be due to a mild alerting effect.

Butikacin is deoxystreptamine aminoglycoside with bactericidal activity with good activity against Staphylococcus aureus and a range of gram-negative bacteria.

Cicrotoic acid is a biochemical drug that acts on bile flow and liquid composition of human bile.

Butaverine is a fatty acid ester with antispasmodic activity which was under development for treatment urinary incontinence

Nanofin is a ganglion blocker alkaloid having nicotinic acetylcholine receptor antagonist action. It has an antihypertensive effect used for mild to moderate hypertension. It was also used for the treatment of eczema and neurodermatitis.